CHMP rejects ofatumumab as maintenanceJune 26, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Obinutuzumab approved to treat FLJune 19, 2016Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
CHMP recommends extending brentuximab approvalMay 28, 2016Lymphoma & Plasma Cell DisordersPharmacyHodgkin Lymphoma
PD-1 inhibitor granted accelerated approval for cHLMay 18, 2016Lymphoma & Plasma Cell DisordersPharmacyHodgkin Lymphoma
Company warns of counterfeit drugMay 10, 2016Leukemia, Myelodysplasia, TransplantationMultiple MyelomaPharmacyTransplantation
FDA grants priority review for blinatumomabMay 5, 2016Leukemia, Myelodysplasia, TransplantationPediatricsPharmacyALL